Status: current, Defined. Date: 30-Apr 2021. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 4555381000168111 | cabotegravir 400 mg / 2 mL modified release injection [1 x 2 mL vial] (&) rilpivirine 600 mg / 2 mL modified release injection [1 x 2 mL vial], 1 pack (medicinal product pack) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 4555391000168114 | cabotegravir 400 mg/2 mL modified release injection [2 mL vial] (&) rilpivirine 600 mg/2 mL modified release injection [2 mL vial], 1 pack | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| cabotegravir 400 mg/2 mL modified release injection [2 mL vial] (&) rilpivirine 600 mg/2 mL modified release injection [2 mL vial], 1 pack | Is a | cabotegravir 400 mg/2 mL modified release injection, 2 mL vial | true | Inferred relationship | Some | ||
| cabotegravir 400 mg/2 mL modified release injection [2 mL vial] (&) rilpivirine 600 mg/2 mL modified release injection [2 mL vial], 1 pack | Is a | rilpivirine 600 mg/2 mL modified release injection, 2 mL vial | true | Inferred relationship | Some | ||
| cabotegravir 400 mg/2 mL modified release injection [2 mL vial] (&) rilpivirine 600 mg/2 mL modified release injection [2 mL vial], 1 pack | has component pack | cabotegravir 400 mg/2 mL modified release injection, 2 mL vial | true | Inferred relationship | Some | ||
| cabotegravir 400 mg/2 mL modified release injection [2 mL vial] (&) rilpivirine 600 mg/2 mL modified release injection [2 mL vial], 1 pack | has component pack | rilpivirine 600 mg/2 mL modified release injection, 2 mL vial | true | Inferred relationship | Some | ||
| cabotegravir 400 mg/2 mL modified release injection [2 mL vial] (&) rilpivirine 600 mg/2 mL modified release injection [2 mL vial], 1 pack | has MPUU | rilpivirine 600 mg/2 mL modified release injection, vial | true | Inferred relationship | Some | 784917800 | |
| cabotegravir 400 mg/2 mL modified release injection [2 mL vial] (&) rilpivirine 600 mg/2 mL modified release injection [2 mL vial], 1 pack | has MPUU | cabotegravir 400 mg/2 mL modified release injection, vial | true | Inferred relationship | Some | 740615755 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Cabenuva (1 x Cabotegravir 400 mg/2 mL vial, 1 x Rilpivirine 600 mg/2 mL vial), 1 pack | Is a | True | cabotegravir 400 mg/2 mL modified release injection [2 mL vial] (&) rilpivirine 600 mg/2 mL modified release injection [2 mL vial], 1 pack | Inferred relationship | Some |
Reference Sets
Medicinal product pack reference set
FHIR